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54 The Journal of Thoracic and CardiovObjectives: There is little experience with telerobotic assistance for video-assisted
thoracic surgical lobectomy. We developed a technique for robotic assistance during
video-assisted thoracic surgical lobectomy and report our initial results.
Methods: Video-assisted thoracic surgical lobectomy with the da Vinci Surgical
System (Intuitive Surgical, Sunnyvale, Calif) was attempted in 34 patients (median
age, 69.0 years; age range, 12-85 years). Robotic instruments were used for
individual dissection of the hilar structures through 2 thoracoscopic ports and a 4-cm
utility incision without rib spreading. Data on patient characteristics and perioper-
ative results were collected prospectively.
Results: Robot-assisted video-assisted thoracic surgical lobectomy was accom-
plished in 30 patients (19 female and 11 male patients). Every type of lobectomy
was performed. Four (4/34 [12%]) patients required conversion to thoracotomy. The
majority of patients had non–small cell lung cancer (32/34 [94%]), and 1 patient
each had a typical carcinoid tumor and an extranodal B-cell lymphoma. Every
patient underwent an R0 resection. The median number of lymph node stations
dissected with robotic assistance was 4 (range, 2-7). Operative mortality was 0%,
with no in-hospital or perioperative deaths. Nine (26%) patients experienced Na-
tional Cancer Institute Common Toxicity Criteria for Adverse Events version 3.0
grade 2 or 3 complications. The median chest tube duration was 3.0 days (range,
2-12 days), and the median length of stay was 4.5 days (range, 2-14 days). The
median operative time was 218 minutes (range, 155-350 minutes).
Conclusions: Robot assistance for video-assisted thoracic surgical lobectomy is
feasible and safe. The utility and advantages of robotic assistance for video-assisted
thoracic surgical lobectomy require further refinement and study of the technique.
The technique of video-assisted thoracic surgery (VATS) pulmonary lobec-tomy was first reported in the early 1990s simultaneously by several au-thors.1-4 Since then, the practice of VATS lobectomy for primary surgical
therapy of early stage non–small cell lung cancer (NSCLC) has been slowly
increasing because of indications that the procedure is safe and oncologically
acceptable in patients with stage I disease.5-11 Limitations of minimally invasive
surgical (MIS) approaches for performance of major thoracic procedures include
2-dimensional imaging, an unsteady camera platform, and limited maneuverability
of instruments used through small non–rib-spreading incisions. In an effort to
improve standard MIS techniques, telerobotic surgery has evolved. The da Vinci
Surgical System (Intuitive Surgical, Sunnyvale, Calif) is a recently developed, US
Food and Drug Administration–approved telerobotic system consisting of 4 com-
ponents, including the Insite vision system, with a true 3-dimensional (3-D) endo-
scope providing a high-resolution binocular view of the surgical field, and the
EndoWrist instrument system, which is capable of 7 degrees of freedom and 2
degrees of axial rotation to replicate human wrist-like movements.12 The advanced
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est potential improvement over straight instruments used in
conventional VATS procedures. Because of this, the da
Vinci Surgical System was initially designed for use in
closed-chest cardiac surgery, and the earliest published ex-
perience was in the area of coronary artery bypass graft-
ing.13 In the field of general thoracic surgery, however, it is
not clear whether this technology has any benefits, and there
are only a few case reports of only a handful of procedures
involving robotic assistance.14-16 For VATS anatomic pul-
monary resections, there are no published data detailing a
robot-assisted technique or its feasibility in a meaningful
cohort of patients. We report our initial experience with
development of an approach for and assessing feasibility of
using the da Vinci Surgical System to perform VATS lo-
bectomy. We reviewed the indications for the procedure, the
technical aspects of incorporating robotic assistance, and
the perioperative outcomes.
Patients and Methods
Patients with clinical stage IA NSCLC or other pathologic tumors
that were peripheral and confined to the lung were considered
eligible for VATS lobectomy. Robotic assistance is defined as use
of the da Vinci Surgical System during a VATS lobectomy for
individual dissection, isolation, and ligation of the pulmonary hilar
structures, as well as mediastinal lymph node dissection. Informed
consent for robotic assistance during VATS lobectomy was ob-
tained. Data on patient characteristics, operative details, and post-
operative recovery were collected in a prospective database ap-
proved by the institutional review board and analyzed
retrospectively. All complications were graded according to the
National Cancer Institute Common Toxicity Criteria for Adverse
Events version 3.0 (http://ctep.cancer.gov/reporting/ctc.html).
Specific details about the development of a technique for robot
assistance during VATS lobectomy, as well as key technical as-
pects, follow below.
Robotic Training and Technique Development
Before implementation of robotics into clinical practice, the au-
thors and the operating room team of nurses, surgical technicians,
and surgical physician assistants (PAs) attended an intense, 2-day
certifying course given by Intuitive Surgical. Use of a human
cadaver model and additional modifications in our institutional dry
laboratory allowed for implementation of robotic assistance into
our established VATS lobectomy technique. Once the entire sur-
Abbreviations and Acronyms
3-D  three dimensional
MIS minimally invasive surgery
NSCLC non–small cell lung cancer
PA  physician assistant
VATS  video-assisted thoracic surgerygical team became proficient with the da Vinci Surgical System,
The Journal of Thoracwe incorporated it into treatment of our patients. The initial 10
cases were performed with a dedicated MIS surgical PA and at
least 2 members of the attending staff working together, one as
the operating surgeon at the surgeon’s console and the other at
the operating room table with the patient. Once each surgeon
became comfortable with the procedure, we were able to incor-
porate the surgical fellows as first assistants. The majority of
procedures are now performed with one attending surgeon, a
surgical fellow, and a surgical PA.
At our institution, the surgeons who perform VATS lobec-
tomy do so through a technique that uses two 1- to 1.5-cm
access incisions and a 4-cm or smaller non–rib-spreading utility
incision. The initial 2 robot-assisted cases used a different
4-incision technique that had the robot positioned perpendicular
to the longitudinal axis of the patient. This was subsequently
modified to conform to our standard VATS lobectomy technique
by bringing in the robot at a 45° angle with respect to the long axis
of the patient.
Preparation of the Robot
The operating room technical staff sets up the da Vinci Surgical
System (robot, surgeon’s console, and Insite vision system) the
evening before its use. In the beginning of the case, the nursing
staff power up the system, run the appropriate diagnostics, and
drape the robotic arms and camera. This requires 2 individuals,
typically takes 20 to 30 minutes for staff who are trained and
familiar with the process, and occurs while the patient is under-
going induction of anesthesia and positioning.
Initial Exploration and Positioning of the Robot
For the intrathoracic portion of the case, the patient is placed in a
maximally flexed lateral decubitus position after single-lung ven-
tilation is established. Initial thoracic exploration is conducted with
conventional thoracoscopy to verify tumor location, establish a
tissue diagnosis if necessary, assess resectability and appropriate-
ness of a VATS approach, and establish the VATS lobectomy
access incisions. The incision for the camera is placed in the 7th or
8th intercostal space at the posterior axillary line. The next incision
is then placed just above the diaphragm posterior to the tip of the
scapula. The lung is retracted posteriorly to identify the hilar
structures. The location of the main utility incision varies depend-
ing on the lobe of interest. For upper lobectomy, it is placed at the
level of the superior vein in the midaxillary line. For middle and
lower lobectomies, the incision is placed one intercostal space
lower. Once the incisions have been made, no additional dissection
is performed. The conventional VATS instrumentation is removed,
and the da Vinci robot is brought into position from the posterior
aspect of the patient, with the center column at an approximately
45° angle with respect to the longitudinal axis of the patient
(Figure 1). This allows for the field of dissection to include the
hilar structures and the majority of the chest.
A 12-mm trocar is placed through the anterior inferior access
incision, and the camera arm is attached to the trocar. The 3-D 30°
scope is introduced through the trocar and secured to the camera
arm. For right-sided procedures, the optimal camera angle is up,
whereas for left-sided procedures, a better view is afforded with
the camera angle down. The positioning of the instrument arms
with attached trocars through the 2 remaining access incisions is
ic and Cardiovascular Surgery ● Volume 131, Number 1 55
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from within the patient’s thorax. Care must be taken to ensure that
each instrument arm has full range of motion and does not collide
with one another or with any portion of the patient (Figure 2). The
surgical instruments are introduced under direct thoracoscopic
vision, and the operating surgeon moves to the surgeon’s console.
Dissection is initiated with a Cadiere forceps in the left arm and the
permanent spatula attached to electrocautery in the right arm.
Robot-Assisted VATS Dissection
Two assistants are required for robot-assisted VATS lobectomy.
The first stands at the anterior aspect of the patient and assists
through the main utility incision by providing additional retraction
of the lung and suction when necessary. The second is positioned
at the posterior access incision. The technical steps for each type
of VATS lobectomy have been described in previous publications
and will not be reviewed here. However, several important aspects
of our technique will be emphasized.
Once a pathologic diagnosis of NSCLC is confirmed, either
preoperatively or intraoperatively, we are in the practice of begin-
ning the procedure with mediastinal lymph node dissection. When
indicated, these are sent for frozen section to rule out occult stage
III disease.
If there are no contraindications to lobectomy, individual iso-
lation of the hilar structures proceeds with dissection around the
Figure 1. Positioning of the da Vinci Surgical System. A, Over-
head view; B, magnified view.hilar vessels and bronchi performed through a combination of
56 The Journal of Thoracic and Cardiovascular Surgery ● Januacautery and sharp and blunt dissection. Complete removal of all
regional nodal tissue is performed. When either a vessel or the
bronchus is mobilized sufficiently, 2 blunt-tipped Cadiere forceps
are used to isolate the structure, using the 7 degrees of freedom to
articulate the instruments at near right angles to do so.
For upper and middle lobectomy, individual ligation and divi-
sion of the hilar structures are performed with endoscopic staplers
introduced through the posterior access incision. This requires
temporary repositioning of the left instrument arm. In contrast, for
lower lobectomy, division of the hilar structures is best performed
by placing the stapling devices through the anterior utility incision,
which requires repositioning of the right instrument arm.
In our technique of VATS lobectomy, completion of the fissure
is performed last, just before removal of the specimen. After
isolation and division of all of the hilar structures, the robot is
removed, and conventional thoracoscopy is re-established to com-
plete the fissure. For upper lobectomy, the entire fissure is divided
with endoscopic staplers; for middle and lower lobectomies, the
anterior portion of the fissure is often divided with electrocautery
in the course of dissection of the hilar structures. The remaining
posterior portion of the fissure is then completed with the endo-
scopic staplers.
Results
Between November 2002 and December 2004, there were
34 consecutive patients who underwent attempted robot-
assisted VATS lobectomy with the da Vinci Surgical Sys-
Figure 2. Robotic instrument configuration.tem. There were 3 additional patients who underwent ex-
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VATS lobectomy. Two had benign lesions and underwent
VATS wedge resection only. One patient was found to have
a lesion invading the pericardium and was converted to a
thoracotomy for lobectomy. The patient characteristics are
listed in Table 1. Upper lobe lesions predominated (24/34
[71%]), with right upper lobe tumors being the most com-
mon.14 Patients were selected for a robot-assisted approach
on the basis of the following criteria: (1) presence of a
localized peripheral lung lesion without evidence of nodal
or extrathoracic spread and (2) adequate cardiopulmonary
reserve to tolerate a lobectomy. Five patients had no tissue
diagnosis and underwent initial VATS and wedge resection
in the same setting, and 6 patients had mediastinoscopy also
in the same setting. The vast majority of our patients had
NSCLC (32/34 [94%]), and 1 patient each had a typical
carcinoid tumor and a primary pulmonary lymphoma.
Those with NSCLC all had clinical stage IA disease preop-
eratively. As a result, only 1 patient had any therapy before
resection. This patient was given a diagnosis of Hodgkin’s
TABLE 1. Patient characteristics and perioperative results
(n  34)
Median age (y) 69.0 (12-85)
M/F sex 13.21
Tumor location
RUL 14
LUL 10
LLL 5
RLL 4
RML 1
Median tumor diameter (cm) 2.0 (0.8-4.0)
Tumor histology
NSCLC 32
Typical carcinoid 1
MALT 1
Pathologic stage (NSCLC, n  32)
T1 N0 M0 (IA) 25
T2 N0 M0 (IB) 3
T1 N1 M0 (IIA) 3
T2 N1 M0 (IIB) 1
Median operative time (min) 218 (155-350)
Median room time (min) 306 (230-433)
Median chest tube duration (d) 3.0 (2-12)
Median length of stay (d) 4.5 (2-14)
Postoperative complications (n  9, 26%)
Supraventricular arrhythmia 6
Hemorrhage 1
Myocardial infarction 1
Prolonged air leak 1
RUL, Right upper lobe; LUL, left upper lobe; LLL, left lower lobe; RLL, right
lower lobe; RML, right middle lobe; NSCLC, non–small cell lung cancer;
MALT, mucosal associated lymphoid tissue.lymphoma and NSCLC simultaneously and was treated at
The Journal of Thoracan outside institution with chemotherapy directed at both
before presentation at our institution.
VATS lobectomy with robotic assistance was completed
in 30 patients. Individual isolation and ligation of all hilar
structures was performed in 24 patients. In 6 of the first 20
patients, robotic assistance was used for a portion of the
hilar dissection, followed by conventional thoracoscopy.
Conversion to thoracotomy was required in 4 (12%) pa-
tients. Three patients were converted for minor bleeding, 2
from cautery injuries to a segmental pulmonary artery in the
course of dissection and 1 during isolation of the superior
pulmonary vein. None of these patients required blood
transfusion intraoperatively or postoperatively. One patient
required conversion because of loss of single-lung isolation.
Table 1 shows the perioperative results. Operative time was
measured from the start of VATS to skin closure. Median
operative time was 218 minutes (range, 155-350 minutes).
Median room time, defined as the total time the patient was
in the room, was 306 minutes (range, 230-433 minutes).
Every type of lobectomy was done, and mediastinal lymph
node dissection was performed in each instance. The me-
dian number of lymph node stations dissected in patients
undergoing successful robot-assisted VATS lobectomy was
4.0 (range, 2-7).
For the patients with NSCLC, the overwhelming major-
ity had adenocarcinoma of some variation (27/32 [84%],
Table 1). Pathologic stage in these patients correlated with
clinical stage (T1 N0 M0, stage IA) in 78% (25/32). Two of
3 patients with pT2 N0 M0 disease had microscopic visceral
pleural invasion, and there were 4 patients with pathologic
stage II disease who had completely resected microscopic
N1 disease. There were no patients with unsuspected stage
III disease, and all underwent R0 resections. The median size
of the lesions pathologically was 2.0 cm (range, 0.8-4.0 cm).
The median chest tube duration for the entire group was
3.0 days (range, 2-12 days), and the median length of stay
was 4.5 days (range, 2-14 days). The complication rate for
all patients was 26% (9/34, Table 1). The most common
complication was supraventricular tachycardia (6/9). All
complications were either National Cancer Institute Com-
mon Toxicity Criteria for Adverse Events version 3.0 grade
2 or 3. One patient with a history of coagulopathy had
postoperative hemorrhage requiring re-exploration, with no
clear source of bleeding identified. One patient experienced
a postoperative myocardial infarction and underwent emer-
gency cardiac catheterization and stent placement. There
were no in-hospital deaths, and the 30-day mortality rate
was 0%.
Discussion
Since the initial series in the early 1990s describing the
technique, VATS lobectomy has not gained widespread
acceptance as a standard approach to early-stage lung can-
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nique, even among its busiest practitioners, and the lack of
a large randomized trial demonstrating equivalency to a
standard thoracotomy approach for the treatment of resect-
able NSCLC. However, with ongoing refinements in mini-
mally invasive techniques and instrumentation and with
detection of primary lung cancers at smaller sizes and
earlier stages, the use of minimally invasive VATS tech-
niques for anatomic pulmonary resections is likely to be-
come more commonplace. One of the newest advances in
minimally invasive surgical intervention is the development
of telerobotics. With its advanced 3-D optics, stable camera
platform, and instrumentation that allows for 7 degrees of
freedom of motion, the da Vinci Surgical System has been
shown to be effective in performing complex cardiovascular
surgical procedures in a closed-chest setting. We hypothe-
sized that use of this technology during VATS lobectomy
would be feasible and safe and wondered whether it af-
forded any advantages over conventional VATS in terms of
ease of anatomic dissection.
There were 2 major reasons that a conscious decision
was made to develop a robotic technique that used the
incisions used for a conventional VATS lobectomy rather
than develop a unique set of incisions. The first was that in
the event of malfunction of the robot or any of the system’s
components that cannot be fixed in a timely fashion, the
remainder of the procedure can be performed with conven-
tional thoracoscopy without the need for additional inci-
sions. The second reason was because there have been no
large series describing a successful technique for robot-
assisted VATS lobectomy, there was no way to know
whether the goal of performing the entire hilar dissection
with robotic instrumentation was technically feasible. In-
deed, the major challenge in developing this technique was
determining the optimal positioning of the surgical cart and
the instrument arms. As a result, the median operative time
for robot-assisted cases was more than 3 hours at 218
minutes. In 2 cases early in the series, the operative time
was well over 5 hours, but as the technique was refined, this
value decreased steadily, such that the operative times in 8
of the last 10 cases have been less than the median value.
This required a multidisciplinary effort from a team of
experienced MIS personnel that included the operating
room nurses and technicians, anesthesiologists, and surgical
staff.
Several key technical points were discovered in refining
this robotic VATS lobectomy technique. First, having the
patients in a lateral decubitus position limits the available
surface area in which to position the camera and instrument
arms. Close attention must be paid to the spacing and the
range of motion of the arms so that they do not collide with
one another or cause undo pressure on any portion of the
patient, particularly the upper extremities.
58 The Journal of Thoracic and Cardiovascular Surgery ● JanuaSecond, it is critical to have assistants at the operating
table who are familiar with conventional VATS lobectomy
techniques, especially with regard to retraction and expo-
sure of pertinent anatomic structures and placement of vas-
cular stapling devices. This is particularly true because the
operating surgeon is seated at the surgeon’s console, away
from the patient.
Third, although there is excellent visual feedback with
the 3-D robotic video system, there is absolutely no tactile
feedback during traction and dissection with robotic instru-
mentation. The same technology that eliminates tremor also
eliminates any sensation of the tissue planes.
Fourth, choosing the appropriate robotic instrumentation
to use during dissection is critical. In doing so, one needs to
remember that the majority of the instruments were de-
signed for use on coronary vessels. The instruments used by
the authors are by no means the only ones that should be
considered. Each individual surgeon must evaluate and test
the instrumentation to determine those that are safe and
effective for dissection.
Finally, because of the reasons listed above and with any
new procedure, we encourage a graded process of develop-
ing experience with the technique. Indeed, in a number of
our early cases, we elected to use the robot in stages before
completing the entire dissection robotically.
An additional issue to be considered is the additional
costs associated with use of the da Vinci Surgical System.
There are 3 major areas of expense: (1) initial capital cost of
the system components, (2) annual maintenance cost, and
(3) cost of disposable materials (instruments and drapes).
Purchase of the robotic system was a capital investment by
our institution, and it is used by multiple surgical services.
The one-time cost of $1 million is not passed on to the
patients. In addition, there is currently no CPT code for
robot-assisted VATS lobectomy, only VATS lobectomy.
Therefore to the best of our knowledge, patients are not
being billed additional fees for our use of the da Vinci
Surgical System. The annual maintenance cost is $100,000.
The robotic instruments have a finite number of uses that
varies from 10 to 12, depending on the instrument. Each
instrument used in our technique costs $2000 and can be
used 10 times, for a cost of $200 per case. The drapes used
for the robot and camera cost $130, so that the total dispos-
able cost per case is $730.
This study suffers from the limitations of any nonran-
domized, retrospectively analyzed cohort of patients, the
most obvious being selection bias. However, a significant
effort was made to select patients on the basis of the
identical criteria that would be used to offer them a nonro-
botic VATS lobectomy. The results of the study demon-
strate that use of the da Vinci Surgical System for the
individual dissection, isolation, and division of the pulmo-
nary hilar structures during VATS lobectomy is feasible and
ry 2006
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consistent with what was expected from pulmonary lobec-
tomy in an elderly population with lung cancer. It is not
surprising that postoperative supraventricular tachycardia
was the most common complication. As with any new MIS
technique, there was a low threshold to convert to thoracot-
omy, and this was required in 12% of cases. This is higher
than those reported in the largest current series of VATS
lobectomy10,11 but acceptable and likely to decrease as more
experience is accumulated. Patients had their chest tubes in
place a median of only 3 days and were discharged in good
condition a median of 4.5 days postoperatively. No patients
required readmission for delayed complications, and there
were no in-hospital or 30-day mortalities. Again, these
results are consistent with the VATS lobectomy experience
from the most recent series.10,11 All patients underwent an
R0 resection, and in the patients with NSCLC who under-
went successful robot-assisted VATS lobectomy, a median
of 4 lymph node stations were resected.
Are there any advantages in using telerobotic surgery
during VATS lobectomy? Strictly speaking, this study was
not designed to answer this question, but it was our obser-
vation that using the da Vinci System provided some en-
hancements over a nonrobotic VATS lobectomy. First, the
3-D Insite camera system resulted in a superior and stable
image for the operating surgeon. Second, the 7 degrees of
freedom of the EndoWrist robotic instruments allowed for
truly intuitive bimanual dissection of the hilar structures.
However, in the end, proving an improvement in the tech-
nical ease of a procedure is quite difficult. Currently, use of
this new technology increases operating room time and adds
cost for use of the robotic instrumentation. The technique is
certainly still evolving and requires further study in clinical
trials before it can be routinely adopted in clinical practice.
The future directions for study of this technology include
further refinement of the technique, validation of the ade-
quacy of the oncologic results, and determination of meth-
ods to compare it with conventional VATS techniques.
The Journal of ThoracWe thank Hugh Thomas for providing the artwork for the
figures.
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